Therefore, spatial implications of NOS2/COX2 and the chemical biology of NO and RNS serve as a crucial roadmap for the design of new clinical trials supporting the development of innovative therapies that disrupt the nitric oxide signaling pathway and ultimately reduce immunosuppression, cancer stemness, and metastasis. The gene discussed is NOS2; the disease is cancer.